We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
175 result(s) found, displaying 111 to 120
-
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Adalimumab
-
-
Prescription medicine registrationActive ingredients: blinatumomab.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for OTEZLA apremilast 30 mg film coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for OTEZLA TITRATION PACK apremilast tablet blister pack.
-
Australian public assessment report (AusPar)Australian Public Assessment Report for blinatumomab (rch)
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Blinatumomab
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Talimogene laherparepvec
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Evolocumab (rch)